Michael S. Aberman, VP Strategy and Investor Relat at REGENERON PHARMACEUTICALS INC (REGN), sold 12,500 shares at $281.72 ($3.5M) on 2013-05-14, disclosed to the SEC on 2013-05-15.
Scheduled sale ($3.5M) by VP Strategy and Investor Relat under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $275.97 | 1,086 | $300K | 8.6% |
| 2 | $275.97 | 5,885 | $1.6M | 46.8% |
| 3 | $278.72 | 701 | $195K | 5.6% |
| 4 | $279.44 | 3,465 | $968K | 27.9% |
| 5 | $280.40 | 1,263 | $354K | 10.2% |
| 6 | $281.72 | 100 |
| $28K |
| 0.8% |
| Total | $277.58 avg | 12,500 | $3.5M | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |